Get Real Time Here
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
| Open17.620 | Close17.890 |
| Vol / Avg.273.861K / 462.930K | Mkt Cap583.462M |
| Day Range17.220 - 17.970 | 52 Wk Range11.330 - 25.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.360 | (EXPECTED) 2023-11-08 | |||||
| REV | 510.000K | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.080 | -1.170 | -0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Guggenheim | Eddie Hickman | Maintains | BuyBuy | Raises | 46.00 | 49.00 |
| 2023-08-14 | Guggenheim | Eddie Hickman | Reiterates | BuyBuy | Maintains | - | 46.00 |
| 2023-08-11 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Lowers | 50.00 | 42.00 |
| 2023-07-26 | HC Wainwright & Co. | Oren Livnat | Maintains | BuyBuy | Raises | 44.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | 1.65% | 583.5M |
| TBPH | Theravance Biopharma | 2.56% | 464.8M |
| GHRS | GH Research | -12.23% | 504.1M |
| SNDL | SNDL | 2.98% | 450.7M |
| WVE | WAVE Life Sciences | -1.88% | 567.2M |
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals's (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the target price for Tarsus Pharmaceuticals (TARS) stock?
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Guggenheim on Monday, September 11, 2023. The analyst firm set a price target for 49.00 expecting TARS to rise to within 12 months (a possible 173.90% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $17.89 last updated October 4, 2023 at 8:20 PM UTC.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There is no dividend information for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.